SCHEMBL5746150

SCHEMBL5746150

CC(C)C[C@@H](C(=O)NO)N1C(=O)CS(=O)(=O)[C@H]1c1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
APEX1 P27695 1/20 0.43
PMP22 Q01453 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
CYP2C19 P33261 1/20 0.43
ADAM17 P78536 2/20 0.39
MMP2 P08253 2/20 0.39
MMP1 P03956 1/20 0.39
MMP9 P14780 1/20 0.39
AVPR1A P37288 1/20 0.36
CCR1 P32246 3/20 0.35
ANPEP P15144 1/20 0.35
MDM2 Q00987 3/20 0.35
TP53 P04637 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5746146 1.00 LMNA (0.43) LMNATHRBAPEX1PMP22TSHR
SCHEMBL6847524 0.76 MDM2 (0.35) ADAM17MMP2AVPR1ACCR1ANPEP
SCHEMBL6847520 0.76 MDM2 (0.35) ADAM17MMP2AVPR1ACCR1ANPEP
SCHEMBL5747229 0.65 KMT2A (0.53) ANPEP
SCHEMBL5747158 0.64 HTT (0.52) LMNAMDM2
SCHEMBL5747163 0.64 HTT (0.52) LMNAMDM2
SCHEMBL5747156 0.64 HTT (0.52) LMNAMDM2
SCHEMBL9668771 0.63 CCR1 (0.40) LMNACCR1MDM2TP53
SCHEMBL9669500 0.63 MDM2 (0.43) CCR1MDM2TP53
SCHEMBL15972682 0.62 MDM2 (0.77) MDM2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173427-B1 HYDROXAMIC ACID DERIVATIVE DAINIPPON SUMITOMO PHARMA CO (JP) 2006-04-05 EP disclosed
US-6713477-B1 1,4-BENZTHIAZINES OR BENZOXAZINES; MATRIX METALLOPROTEINASE INHIBITORS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-03-30 US disclosed